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Lemierre syndrome is arareclinicalentity which
is characterised by septicaemia arising from a
headandnecksource,complicatedbythrombosis
of the ipsilateral internal jugular vein with
embolisation to various sites, most usually the
lungs. It is important to diagnose the syndrome
correctly since its treatment is different from
pulmonary emboli and uncomplicated ENT
infections and if untreated may be associated
with high mortality. We present the occurrence
ofthis syndrome in a 14 year-old girl whose site
of primary infection was the middle ear; the
outcome in this case was favourable.
INTRODUCTION
Lemierre syndrome, described as the 'forgotten
disease'' although very uncommon2 is an
infection-relatedsyndromewhichisimportantto
diagnose accurately since its mortality may be
high.
CASEREPORT A 14-yearoldgirl,withahistory
of chronic mastoiditis, who gave a three-week
history ofleft otalgia and headache presented to
hospitalwithworseningpain,dizziness,vomiting
andrigorsfollowingsevendaysoforalamoxicillin
for presumed acute otitis media. She was febrile
and had cervical lymphadenopathy with neck
pain and tenderness. A diagnosis of acute
suppurative otitis media was made for which she
receivedintravenous cefotaxime2g8-hourly and
metronidazole 500mg 8-hourly.
Over the following five days she had persisting
fever and worsening left-sided neck pain.
Furthermore, shebecame dyspnoeic, developing
pleuritic chest pain and haemoptysis; measured
oxygen saturation on room air was 88%.
Computerised tomography (CT) revealed
thrombus, bubbles of gas in the left internal
jugular vein (Fig. 1) and several ill defined
Fig 1. CT scan of neck highlighting the thrombus
(manifestbythelackofcontrastagentseen) inthe
left internal jugular vein.
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Fig 2. CT scan of chest showing several opacities with
surrounding infiltrateattributed to septic emboli.
Fig 3. CT scan of head showing mastoid sclerosis,
especially on left.
opacities in the lung fields consistent with septic
pulmonary emboli (Fig. 2). Further imaging
identified bilateral sclerosis of the mastoids,
greater on the left, consistent with chronic
mastoiditis; small gas collections and soft tissue
changesconsistentwithacuteinflammationwere
alsopresent(Fig. 3). Bloodcultureswerepositive
for Bacteroides fragilis and an unidentified
anaerobic Streptococcus sp.
Thepatientunderwentaleftsidedmodifiedradical
mastoidectomy andremoval ofgranulations. She
received 14 days of intravenous piperacillinl/
tazobactam 4.5g 8-hourly and metronidazole
500mg 6-hourly followedby afurther 14 days of
oral co-amoxiclav and metronidazole. Initial
anticoagulation was with subcutaneous
enoxaparin 100mg daily and, subsequently,
warfarin for a total of two months. She remains
well six months later.
DISCUSSION
Although the correlation between oropharyngeal
infection and sepsis was first described by
Courmant and Cade in 1900,3 Lemierre was the
first to characterise the syndrome in 1936 and
published a series of20 cases, 18 ofwhom died.4
Alston subsequently reported a series of 280
episodes; these typically occurred in young,
otherwise healthy patients.5 The most frequent
site ofprimary infection was the oropharynx and
ranged from mild to fulminant in severity. The
syndrome characteristically associates such
infection with ipsilateral internal jugular vein
thrombosiscomplicatedby septicemboli,usually
to the lungs, with persistent fever; the usual
organism isolated from blood is Fusobacterium
necrophorum.
Lemierre, in his original description,
acknowledged alternative extrapharyngeal
sources of infection which included the middle
ear, female urogenital tract and gastrointestinal
tract. Subsequently many sites of septic emboli
have been identified such as bone, meninges,
abdominal viscera, peritoneum and soft tissue.5
Furthermore several alternative pathogens have
been proposed, including Bacteroides, as
organismscapableofprecipitatingthesyndrome.
It is important to make the correct diagnosis to
allow selection of appropriate treatment; this is
differentfrom that which isusual forpharyrigitis,
otitis media, or thromboembolic disease.
Debridementoftheprimaryfocusis animportant
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interventionandbroadspectrumantibiotictherapy
with potent anaerobic activity is the cornerstone
of management; examples may include either
clindamycin or a combination of a beta-lactam
and metronidazole. The preferred duration of
antibiotic therapy is 2-6 weeks, with conversion
from intravenous to oral administration when
marked improvement with defervescence,
resolution of leucocytosis and falling
inflammatory indices are observed. Mortality
today is less than 17%,6 much lower than in the
preantibiotic era.
Furthermore, therole ofanticoagulation remains
unclear since no randomised controlled trials
exist to test the hypothesis that this is beneficial.
Interestingly, case series suggest that those who
are anticoagulated have similaroutcome to those
whoarenot;indeedasmallnumbersufferadverse
events attributable to warfarin therapy.7 Some
have recommended that, except when cavernous
sinus thrombosis is present, anticoagulation is
withheld.6
Lemierre remarked, in his original description,
that upon observation of the constellation of
findings which characterise the syndrome
"mistake is almost impossible".4 However,
unfamiliarity withthis disease may confound the
diagnosis and lead to missed therapeutic
opportunity. The clinical lesson is, therefore,
straightforward: when presented with a young,
previously well patient who has a primary head
and neck infection but a clinical illness out of
proportion with this, often with symptoms at a
discrete site, remember the forgotten disease.
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